Business & regional news

Month Year

Month Year

Sep 16, 2022

FIRST-EVER COMPARISON OF MICROCT AND HISTOLOGY IN SELF-EXPANDING TRANSCATHETER AORTIC VALVE REPLACEMENT PATIENTS WITH HYPO-ATTENUATED LEAFLET THICKENING

TCT 2022: Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets Medtronic today announced findings from its Pathological Study of Hypo-Attenuated...
- Structural Heart and Aortic
Sep 16, 2022

MEDTRONIC ANNOUNCES FULL MARKET LAUNCH IN U.S. OF EVOLUT™ FX NEXT-GEN TAVR SYSTEM FOR TREATMENT OF SYMPTOMATIC SEVERE AORTIC STENOSIS

TCT 2022: Medtronic Unveils Latest Transcatheter Aortic Valve Replacement Data in Late-Breaking Clinical Science and Presentations
- Structural Heart and Aortic
May 17, 2022

Optimized procedure and care pathway with Medtronic Evolut™ TAVR System demonstrates excellent valve performance and procedural outcomes

Mid-term results of Optimize PRO clinical study reinforces benefits of predictability and control using cusp overlap technique
- Structural Heart and Aortic
May 2, 2022

Medtronic announces first enrollment in pivotal trial of patients with moderate, symptomatic aortic stenosis

EXPAND TAVR II Pivotal Trial evaluating the Evolut™ TAVR platform in a new patient population
- Structural Heart and Aortic
Apr 19, 2022

Medtronic Announces Collaboration with Cydar Medical to Bring Endovascular Aortic Care to a New Level with Cutting-Edge Artificial Intelligence Technology
- Structural Heart and Aortic

Show per page